Fill Finish Catridge Market: Current Analysis and Forecast (2022-2028)

Fill Finish Catridge Market: Current Analysis and Forecast (2022-2028)

Fill finish cartridge is a process of introducing the drug product into the cartridge under aseptic conditions, which is critical to ensure the safety and efficacy of the product. The market for fill finish cartridges is growing at a tremendous rate owing to the rising number of pharmaceutical companies and the surge in the demand for biologics drugs in the management of diabetes, and other chronic diseases. Moreover, the rising penetration of contract manufacturing organizations (CMO) in various biotech companies is also considered a significant factor in driving the market growth.

The Fill Finish Cartridge Market is expected to grow at a steady rate of around 9.7% owing to a surge in the prevalence of diabetes. According to the data from the International Diabetes Federation 2021 report, the prevalence of type 2 diabetes was around 405.6 million, which is projected to increase to approximately 510.8 million by 2030. Moreover, as per the CDC, approximately 37.3 million people in the U.S. had diabetes in 2020, with 28.7 million diagnosed and 8.5 million undiagnosed cases. Furthermore, about 96 million people aged 18 years and older have prediabetes. Thus, the surge in the prevalence of diabetes will have a positive impact on the growth of the market during the forecast period.

• Based on cartridge size, the market is segmented into less than 1 ml, 1ml-3ml, and more than 3ml. The 1ml-3ml category held the dominant share in the market in 2021. This is mainly due to the surge in the incidences of diabetes, the rising affordability of insulin cartridges, advancements in drug delivery systems, and the growing awareness regarding the treatment of the disease.
• On the basis of drug type, the market is bifurcated into biologics and others. The others segment, including dental anesthesia, is expected to grow with a high CAGR during the forecast period as a result of rising disposable income and increasing oral awareness. Apart from this, countries such as China and India are currently the greatest producers and consumers of tobacco with the lowest awareness levels about smoking hazards. These are the elements that are anticipated to fuel the market during the forecast period.
• On the basis of injection devices, the market is bifurcated into pens and autoinjectors. The pens held the dominant share in the market in 2021. The most common insulin administration tools used by diabetic patients, particularly in industrialized nations, are insulin pens. Insulin pens are widely used by insulin users due to their simplicity of use and precision in delivery. Moreover, rising technological advancements is also driving the adoption of pens in the global market. For instance, iSenz is an adaptor for smart insulin pens that possess a feature to detect the insulin level, by scanning. It provides the correct angles for injections in order to optimize the injection sites for diabetes.
• For a better understanding of the market adoption of the neoantigen cancer vaccine, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is anticipated to grow with significant CAGR during the forecast period, owing to factors, including rising geriatric population and target populations, increasing number of collaborations for the development of biosimilars, geographic expansion of key players, and active participation of government & nonprofit organizations in the market space. For instance, in July 2021, global contract development and manufacturing organization (CDMO), Recipharm, announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The above-mentioned factors are driving the regional market during the forecast period.
• Some of the major players operating in the market include Berkshire Sterile Manufacturing, Syntegon Technology, Novocol Pharma, Recipharm AB, SCHOTT Pharma, Vetter, Sever Pharma Solutions, Cytiva, Grand River Aseptic Manufacturing, and Lonza.